Ryan White Care Hepatitis C & B Language
NATAP Webinars
Aging & Heart Disease in HIV: Where are we now in 2024?
Friday, May 10th, 2024 - 12:30pm
Click To Register:
Aging & Heart Disease in HIV: Where are we now in 2024?
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
CROI:
31st Conference on Retroviruses and Opportunistic Infection
Eric S. Daar, M.D. - Chief, Division of HIV Medicine Harbor-UCLA Medical Center Professor of Medicine David Geffen School of Medicine at UCLA - (03/26/24)
 
Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV Infection
- (05/08/24)
 
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
 
CROI:
Epidemiologic Burden of Hepatitis D Virus in the United States
- (03/28/24)
 
CROI:
INCIDENCE AND OUTCOME OF HDV INFECTION IN PEOPLE WITH HIV IN THE ERA OF TENOFOVIR-CONTAINING THERAPY
- (03/28/24)
 
CROI:
Efficacy and Safety of Bulevirtide 2 mg or 10 mg for 96 Weeks in Chronic Hepatitis Delta, Including in 2 Patients With HIV/Hepatitis B Virus/Hepatitis Delta Virus
- (03/28/24)
 
More Hep D Articles...
 
Aging & Perinatally HIV Infected
 
CROI:
EPIGENETIC IMPACT IN CSF CELLS FROM 48 WEEKS OF ADJUNCTIVE TELMISARTAN IN ACUTE HIV
- (04/15/24)
 
More Aging & HIV Articles...
 
PrEP
 
Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment & Prevention for People Experiencing Homelessness
- (04/03/24)
 
CROI:
EHE "May not be feasible in many US cities" - Charting Achievable Milestones for HIV Care Enhancement and Prevention in the US Through 2035
- (04/02/24)
 
CROI:
First Case of HIV Seroconversion With Emergence of InSTI Resistance on CAB-LA PrEP in Routine Care
- (04/02/24)
 
CROI:
HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
- (04/02/24)
 
CROI:
A Randomized Trial Switching Adults ≥ 60 Years Old From First-Line ART to B/F/TAF: Week 48 Results
- (03/28/24)
 
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
Hepatitis C Surveillance 2022: new acute, chronic HCV cases; racial disparity; death rates; switch from IDU to snorting, smoking
- (04/15/24)
 
Integrated Hepatitis C–Opioid Use Disorder Care Through Facilitated Telemedicine A Randomized Trial
- (04/15/24)
 
AASLD:
Implementation of Universal Hepatitis C Virus Screening in a Tertiary Care Cancer Center
- (04/15/24)
 
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
 
WHO sounds alarm on viral hepatitis infections claiming 3500 lives each day
- (04/15/24)
 
New WHO HBV Treatment Recommendations, HDV Too; HCC monitoring; mother-to-child HBV transmission prevention
- (04/15/24)
 
CROI:
Transaminase elevations among patients with occult HBV infection on two-drug antiretroviral regimens
- (03/21/24)
 
CROI:
Hepatitis B Reactivation in PLWH With Anti-Core Antibody After Switch to an Anti-HBV Sparing Regimen
- (03/21/24)
 
CROI:
HepB-CpG Vaccine Superior to HepB-alum in HIV Group With Prior Nonresponse
- Mark Mascolini (03/21/24)
 
CROI:
HepB-CpG vaccine is superior to HepB-alum in people with HIV and prior vaccine non-response (A5379)
- (03/15/24)
 
CROI:
Factors Associated With HBV Response to B/F/TAF Versus DTG + F/TDF at Week 96 in People With HIV-1 and HBV
- (03/15/24)
 
Moving beyond the guidelines to improve detection of viral hepatitis (HBV) and linkage to care
- (02/07/23)
 
HBV functional cure finding-Cytosine base editing inhibits Hepatitis B Virus replication and reduces HBsAg expression in vitro and in vivo
- (01/08/23)
 
More Hep B Articles...
 
Fatty Liver, NAFLD, NASH
 
Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis
- (03/20/24)
 
CROI:
Effects of Semaglutide on Muscle Structure and Function in the SLIM Liver Study
- (03/12/24)
 
CROI:
Semaglutide Lowers Some Inflammation Markers in HIV Lipohypertrophy
- Mark Mascolini (03/12/24)
 
CROI:
Low-Dose Semaglutide Cuts Weight, Triglycerides, and Glucose in HIV MASLD Group
- Mark Mascolini (03/12/24)
 
CROI:
Race/Ethnicity and Risk of NAFLD and Clinically Significant Fibrosis in Persons Living with HIV
- (03/12/24)
 
CROI:
NAFLD and Advanced Fibrosis Are Common in Adults With HIV and Associated With Unique Histology
- (03/12/24)
 
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
22 February 2024 - 23 February 2024 Nairobi Kenya
https://academicmedicaleducation.com/meeting/african-workshop-hiv-women-2024
May 2-4, 2024 Atlanta, GA
https://acthiv.org/acthiv-2024-program/
https://ddw.org/
https://easl.eu/event/easl-congress-2024/
https://asm.org/Events/ASM-Microbe/Home
Munich, Germany, and virtually from 22 to 26 July 2024.
Pre-conferences will be held on 20 and 21 July.
https://www.iasociety.org/conferences/aids2024
Conference on Liver Disease in Africa (COLDA) 2024
19 September 2024 - 21 September 2024 Egypt
https://academicmedicaleducation.com/meeting/conference-liver-disease-africa-colda-2024
18 September 2024 - 20 September 2024 Liverpool, United Kingdom
https://academicmedicaleducation.com/meeting/international-workshop-clinical-pharmacology-hiv-hepatitis-and-other-antiviral-drugs-2024
https://www.iasociety.org/conferences/hivr4p2024/registration
https://idweek.org/#
24 October 2024 - 25 October 2024 United States
Washington DC, United States
https://academicmedicaleducation.com/meeting/international-workshop-hiv-aging-2024
10-13 November 2024
https://hivglasgow.org/
San Diego, California
https://www.aasld.org/liver-meeting-tlm-2024
https://informedhorizonseducation.com/hiv-respidart-2024